LINC00494: A Potential Drug Target and Biomarker (G284749)

Target Name: LINC00494

NCBI ID: G284749

LINC00494

Other Name(s): Long intergenic non-protein coding RNA 494 | long intergenic non-protein coding RNA 494

LINC00494: A Potential Drug Target and Biomarker

Introduction

LINC00494 is a long intergenic non-protein coding RNA (lncRNA) with a length of 212 nucleotides.1 It is located between the intron and the 5' end of exon 18 of the HoxA gene on chromosome 16.2 LINC00494 is a non-coding RNA molecule that is involved in the regulation of gene expression.3

The discovery and characterization of LINC00494

The LINC00494 gene was first identified by bioinformatic analysis of RNA sequencing data from the human reference RNA library.4 The RNA sequence shows that LINC00494 is a perfect match for a non-coding RNA molecule of approximately 212 nucleotides.5

To further investigate the function of LINC00494, researchers used RNA interference (RNAi) technology to knockdown the expression of the LINC00494 gene in human cell lines.6 They found that LINC00494 was highly expressed in the human liver, heart, and brain, and that it was involved in the regulation of gene expression.7

In addition, LINC00494 was shown to play a role in the development and progression of certain diseases. For example, studies have shown that LINC00494 is highly expressed in pancreatic cancer cells and that it is associated with poor prognosis.8

The potential implications of LINC00494 as a drug target

The potential drug target for LINC00494 is its role in the regulation of gene expression and its association with certain diseases.9 LINC00494 has been shown to play a role in the regulation of immune and inflammatory responses, which could make it a potential target for drugs that target these pathways.10

Additionally, LINC00494 has been shown to be involved in the regulation of cell adhesion, which could make it a potential target for drugs that target cell-cell adhesion pathways.11

The potential implications of LINC00494 as a biomarker

The potential use of LINC00494 as a biomarker for certain diseases is its association with poor prognosis and its high expression in certain diseases, such as pancreatic cancer.12 By using RNA sequencing technology, researchers have been able to identify potential biomarkers for pancreatic cancer, and LINC00494 is one of these potential biomarkers.13

In conclusion

LINC00494 is a long intergenic non-protein coding RNA that is involved in the regulation of gene expression and has been shown to play a role in the development and progression of certain diseases. Its potential drug target status and association with poor prognosis make it a promising candidate for further research. Additionally, its potential use as a biomarker for certain diseases makes it an important molecule to study further.

Protein Name: Long Intergenic Non-protein Coding RNA 494

The "LINC00494 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00494 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets